radicava
Commercial- Indications
- ALS
Company intelligence / Profile preview
Bain Capital Life Sciences is an active global investment platform focused on biopharmaceuticals, medical devices, diagnostics, and life science tools. Since its founding in 2016, it has raised over $6.7 billion across four funds and invested in more than 70 companies that have initiated over 100 clinical trials and achieved at least 16 regulatory approvals. The company does not itself conduct clinical trials or develop drugs but provides capital and strategic support to companies at various stages of development.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bain Capital Life Sciences.